Abstract:Microgravity and space environment has been linked to deficits in neuromuscular and cognitive capabilities, hypothesized to occur due to accelerated aging and neurodegeneration in space. While the specific mechanisms are still being investigated, spaceflight-associated neuropathology is an important health risk to space astronauts and tourists, and is being actively investigated for the development of appropriate countermeasures. However, such space-induced neuropathology offers an opportunity for accelerated screening of therapeutic targets and lead molecules for treating neurodegenerative diseases. Here we show, a proof-of-concept high-throughput target screening (on Earth), target validation, and mitigation of microgravity-induced neuropathology using our Nanoligomer™ platform, onboard the 43-day SpaceX CRS-29 mission to the International Space Station (ISS). First, comparing 3D healthy and diseased pre-frontal cortex (PFC, for cognition) and motor neuron (MN, for neuromuscular function) organoids, we assessed space-induced pathology using biomarkers relevant to Alzheimer’s Disease (AD), Frontotemporal Dementia (FTD), and Amyotrophic Lateral Sclerosis (ALS). Both healthy and diseased PFC and MN organoids showed significantly enhanced neurodegeneration in space, as measured through relevant disease biomarkers, when compared to their respective Earth controls. Second, we tested the top two lead molecules, NI112 which targeted NF-κB, and NI113 that targeted IL-6. We observed that these Nanoligomers significantly mitigate the AD, FTD, and ALS relevant biomarkers like amyloid beta-42 (Aβ42), phosphorylated Tau (pTau), Kallikrein (KLK-6), Tar DNA-binding protein 43 (TDP-43), and others. Moreover, the 43-day Nanoligomer treatment of these brain organoids did not appear to cause any observable toxicity or safety issues in the target organoid tissue, suggesting good tolerability for these molecules in the brain at physiologically relevant doses. Together, these results show significant potential for both the development and translation of NI112 and NI113 molecules as potential neuroprotective countermeasures for safer space travel, and demonstrate the usefulness of the space environment for rapid, high-throughput screening of targets and lead molecules for clinical translation. We assert that the use of microgravity in drug development and screening may ultimately benefit millions of patients suffering from debilitating neurodegenerative diseases on Earth.

Therapeutic Role of Probiotics in Gut-Brain Axis Under Microgravity

Transcriptome Sequencing Reveals the Promotion of Apoptosis and M1 Polarization of Microglia under Simulated Microgravity

Prospective Use of Probiotics to Maintain Astronaut Health during Spaceflight

Microglial activation in spaceflight and microgravity: potential risk of cognitive dysfunction and poor neural health

An integrated omics analysis: impact of microgravity on host response to lipopolysaccharide in vitro

Gut microbiome and human health under the space environment

Effects of Simulated Microgravity on the Expression of Presynaptic Proteins Distorting the GABA/glutamate Equilibrium – A Proteomics Approach

Investigation on P-Glycoprotein Function and Its Interacting Proteins under Simulated Microgravity

Research Progress on the Mechanisms and Effects of Microgravity on Cognitive Function of Brain

Microgravity-driven remodeling of the proteome reveals insights into molecular mechanisms and signal networks involved in response to the space flight environment

The effects of microgravity on cellular elements of the central nervous system - astrocytes, microglia, neurons, oligodendrocytes, and oligodendrocyte precursor cells

Current Knowledge about the Impact of Microgravity on Gene Regulation

Microgravity induces proteomics changes involved in endoplasmic reticulum stress and mitochondrial protection

Inflammasome-Inhibiting Nanoligomers are Neuroprotective Against Space-Induced Pathology in Healthy and Diseased 3D Human Motor and Pre-Frontal Cortex Brain Organoids

Host-microbe interactions in microgravity: assessment and implications

Structural and functional changes in the brain of cosmonauts under the influence of microgravity

Gut matters in microgravity: potential link of gut microbiota and its metabolites to cardiovascular and musculoskeletal well-being

Inflammasome-Inhibiting Nanoligomers Are Neuroprotective against Space-Induced Pathology in Healthy and Diseased Three-Dimensional Human Motor and Prefrontal Cortex Brain Organoids

Response of human gut microbiota under simulated microgravity

Pan‐omic Approaches to Study the Effect of Microgravity on Skin Endothelial Cells Submitted to Endotoxic Insult

Latest knowledge about changes in the proteome in microgravity